Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0129 | 0.2906 | 0.3452 |
Echinococcus multilocularis | geminin | 0.0205 | 0.5578 | 0.5578 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0129 | 0.2906 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.044 | 0.0788 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.044 | 0.0522 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0046 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0129 | 0.2906 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.8418 | 1 |
Onchocerca volvulus | 0.0129 | 0.2906 | 1 | |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0129 | 0.2906 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0129 | 0.2906 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0129 | 0.2906 | 0.5211 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0129 | 0.2906 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0046 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.2906 | 0.5211 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0129 | 0.2906 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0046 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.044 | 0.0788 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5578 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0129 | 0.2906 | 0.3452 |
Echinococcus multilocularis | tumor protein p63 | 0.0331 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.5578 | 0.5578 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0129 | 0.2906 | 0.2906 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0129 | 0.2906 | 0.2906 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0129 | 0.2906 | 0.3452 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0129 | 0.2906 | 0.3452 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5578 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.8418 | 0.8418 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0129 | 0.2906 | 0.2906 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0129 | 0.2906 | 0.2906 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0094 | 0.0112 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.2906 | 0.5211 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0129 | 0.2906 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0046 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0046 | 0 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.8418 | 0.8418 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.8418 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0129 | 0.2906 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0046 | 0 | 0.5 |
Onchocerca volvulus | 0.0048 | 0.0094 | 0.0323 | |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0048 | 0.0094 | 0.0168 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0129 | 0.2906 | 0.2906 |
Onchocerca volvulus | 0.0058 | 0.044 | 0.1513 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0129 | 0.2906 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0129 | 0.2906 | 0.3452 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.2906 | 0.5211 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0129 | 0.2906 | 0.2906 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0046 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0046 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0045 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.